Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. [electronic resource]
Producer: 20061121Description: 1560-6 p. digitalISSN:- 1558-3597
- Angina Pectoris -- blood
- Angioplasty, Balloon, Coronary -- adverse effects
- Atorvastatin
- Cardiotonic Agents -- therapeutic use
- Cell Adhesion Molecules -- blood
- Coronary Disease -- blood
- E-Selectin -- blood
- Heart Injuries -- epidemiology
- Heptanoic Acids -- therapeutic use
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Incidence
- Intercellular Adhesion Molecule-1 -- blood
- Multicenter Studies as Topic
- Pyrroles -- therapeutic use
- Vascular Cell Adhesion Molecule-1 -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.